Related Experiment Video
Updated: Jul 15, 2026

08:52
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
Increasing osteoblastic lesions as a manifestation of a major response to gefitinib
1University of Colorado Health Sciences Center, Boulder, Colorado, USA. david.garfield@earthlink.net
Abstract
No abstract available in PubMed .
